Evidence map›Paper›PMID 34728775›Full record

ArticleInternational journal of obesity (2005)2022

Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB

Tatu Kantonen, Laura Pekkarinen, Tomi Karjalainen, Marco Bucci, Kari Kalliokoski, Merja Haaparanta-Solin, Richard Aarnio, Alex M Dickens, Annie von Eyken, Kirsi Laitinen and 7 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of obesity (2005), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Endogenous Opioid Release After Orgasm in Man: A Combined PET/Functional MRI Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Tatu KantonenTurku PET Centre, University of Turku, Turku, FI-20521, Finland. taskan@utu.fi.ORCID http://orcid.org/0000-0002-2336-0426
Laura PekkarinenTurku PET Centre, University of Turku, Turku, FI-20521, Finland.ORCID http://orcid.org/0000-0002-5596-0485
Tomi KarjalainenTurku PET Centre, University of Turku, Turku, FI-20521, Finland.
Marco BucciTurku PET Centre, University of Turku, Turku, FI-20521, Finland.
Kari KalliokoskiTurku PET Centre, University of Turku, Turku, FI-20521, Finland.
Merja Haaparanta-SolinTurku PET Centre, University of Turku, Turku, FI-20521, Finland.
Richard AarnioTurku PET Centre, University of Turku, Turku, FI-20521, Finland.ORCID http://orcid.org/0000-0002-6420-514X
Alex M DickensTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, FI-20500, Finland.
Annie von EykenTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, FI-20500, Finland.
Kirsi LaitinenInstitute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, FI-20500, Finland.ORCID http://orcid.org/0000-0001-5245-8118
Noora HouttuInstitute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, FI-20500, Finland.
Anna K KirjavainenTurku PET Centre, University of Turku, Turku, FI-20521, Finland.
Semi HelinTurku PET Centre, University of Turku, Turku, FI-20521, Finland.
Jussi HirvonenTurku PET Centre, University of Turku, Turku, FI-20521, Finland.
Tapani RönnemaaDepartment of Endocrinology, Turku University Hospital, Turku, FI-20521, Finland.
Pirjo NuutilaTurku PET Centre, University of Turku, Turku, FI-20521, Finland.ORCID http://orcid.org/0000-0001-9597-338X
Lauri NummenmaaTurku PET Centre, University of Turku, Turku, FI-20521, Finland.
University of Turku · FIÅbo Akademi University · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity is a pressing public health concern worldwide. Novel pharmacological means are urgently needed to combat the increase of obesity and accompanying type 2 diabetes (T2D). Although fully established obesity is associated with neuromolecular alterations and insulin resistance in the brain, potential obesity-promoting mechanisms in the central nervous system have remained elusive. In this triple-tracer positron emission tomography study, we investigated whether brain insulin signaling, μ-opioid receptors (MORs) and cannabinoid CB

methodsSubjects were 41 young non-obese males with variable obesity risk profiles. Obesity risk was assessed by subjects' physical exercise habits, body mass index and familial risk factors, including parental obesity and T2D. Brain glucose uptake was quantified with [

resultsSubjects with higher obesity risk had globally increased insulin-stimulated brain glucose uptake (19 high-risk subjects versus 19 low-risk subjects), and familial obesity risk factors were associated with increased brain glucose uptake (38 subjects) but decreased availability of MORs (41 subjects) and CB

conclusionsThese results suggest that the hereditary mechanisms promoting obesity may be partly mediated via insulin, opioid and endocannabinoid messaging systems in the brain.

Indexed as

AdultBody Mass IndexCerebrumFemaleFinlandGlucose IntoleranceHumansLinear ModelsMaleObesityPositron-Emission TomographyReceptor, Cannabinoid, CB1Receptors, Opioid, muRisk FactorsReceptor, Cannabinoid, CB1Receptors, Opioid, mu

Identifiers

PMID34728775
PMCPMC8794779
OpenAlexW3208820743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.